Pınar, İbrahim E. and Ozkocaman, V. 2023. Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma. The European Research Journal. 9, 6 (Nov. 2023), 1483–1492. DOI:https://doi.org/10.18621/eurj.1359362.